Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Genomic Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Liquid Biopsy
1.2.3 Tissue Biopsy
1.3 Market by Application
1.3.1 Global Lung Cancer Genomic Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals/Clinics
1.3.3 Research Organization
1.3.4 Diagnostic Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Genomic Testing Market Perspective (2018-2033)
2.2 Global Lung Cancer Genomic Testing Growth Trends by Region
2.2.1 Lung Cancer Genomic Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Lung Cancer Genomic Testing Historic Market Size by Region (2018-2023)
2.2.3 Lung Cancer Genomic Testing Forecasted Market Size by Region (2024-2033)
2.3 Lung Cancer Genomic Testing Market Dynamics
2.3.1 Lung Cancer Genomic Testing Industry Trends
2.3.2 Lung Cancer Genomic Testing Market Drivers
2.3.3 Lung Cancer Genomic Testing Market Challenges
2.3.4 Lung Cancer Genomic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Lung Cancer Genomic Testing by Players
3.1.1 Global Lung Cancer Genomic Testing Revenue by Players (2018-2023)
3.1.2 Global Lung Cancer Genomic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Lung Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Lung Cancer Genomic Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Lung Cancer Genomic Testing Market Concentration Ratio
3.4.1 Global Lung Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Genomic Testing Revenue in 2022
3.5 Global Key Players of Lung Cancer Genomic Testing Head office and Area Served
3.6 Global Key Players of Lung Cancer Genomic Testing, Product and Application
3.7 Global Key Players of Lung Cancer Genomic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Genomic Testing Breakdown Data by Type
4.1 Global Lung Cancer Genomic Testing Historic Market Size by Type (2018-2023)
4.2 Global Lung Cancer Genomic Testing Forecasted Market Size by Type (2024-2033)
5 Lung Cancer Genomic Testing Breakdown Data by Application
5.1 Global Lung Cancer Genomic Testing Historic Market Size by Application (2018-2023)
5.2 Global Lung Cancer Genomic Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Lung Cancer Genomic Testing Market Size (2018-2033)
6.2 North America Lung Cancer Genomic Testing Market Size by Type
6.2.1 North America Lung Cancer Genomic Testing Market Size by Type (2018-2023)
6.2.2 North America Lung Cancer Genomic Testing Market Size by Type (2024-2033)
6.2.3 North America Lung Cancer Genomic Testing Market Share by Type (2018-2033)
6.3 North America Lung Cancer Genomic Testing Market Size by Application
6.3.1 North America Lung Cancer Genomic Testing Market Size by Application (2018-2023)
6.3.2 North America Lung Cancer Genomic Testing Market Size by Application (2024-2033)
6.3.3 North America Lung Cancer Genomic Testing Market Share by Application (2018-2033)
6.4 North America Lung Cancer Genomic Testing Market Size by Country
6.4.1 North America Lung Cancer Genomic Testing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Lung Cancer Genomic Testing Market Size by Country (2018-2023)
6.4.3 North America Lung Cancer Genomic Testing Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Lung Cancer Genomic Testing Market Size (2018-2033)
7.2 Europe Lung Cancer Genomic Testing Market Size by Type
7.2.1 Europe Lung Cancer Genomic Testing Market Size by Type (2018-2023)
7.2.2 Europe Lung Cancer Genomic Testing Market Size by Type (2024-2033)
7.2.3 Europe Lung Cancer Genomic Testing Market Share by Type (2018-2033)
7.3 Europe Lung Cancer Genomic Testing Market Size by Application
7.3.1 Europe Lung Cancer Genomic Testing Market Size by Application (2018-2023)
7.3.2 Europe Lung Cancer Genomic Testing Market Size by Application (2024-2033)
7.3.3 Europe Lung Cancer Genomic Testing Market Share by Application (2018-2033)
7.4 Europe Lung Cancer Genomic Testing Market Size by Country
7.4.1 Europe Lung Cancer Genomic Testing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Lung Cancer Genomic Testing Market Size by Country (2018-2023)
7.4.3 Europe Lung Cancer Genomic Testing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Lung Cancer Genomic Testing Market Size (2018-2033)
8.2 China Lung Cancer Genomic Testing Market Size by Type
8.2.1 China Lung Cancer Genomic Testing Market Size by Type (2018-2023)
8.2.2 China Lung Cancer Genomic Testing Market Size by Type (2024-2033)
8.2.3 China Lung Cancer Genomic Testing Market Share by Type (2018-2033)
8.3 China Lung Cancer Genomic Testing Market Size by Application
8.3.1 China Lung Cancer Genomic Testing Market Size by Application (2018-2023)
8.3.2 China Lung Cancer Genomic Testing Market Size by Application (2024-2033)
8.3.3 China Lung Cancer Genomic Testing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Lung Cancer Genomic Testing Market Size (2018-2033)
9.2 Asia Lung Cancer Genomic Testing Market Size by Type
9.2.1 Asia Lung Cancer Genomic Testing Market Size by Type (2018-2023)
9.2.2 Asia Lung Cancer Genomic Testing Market Size by Type (2024-2033)
9.2.3 Asia Lung Cancer Genomic Testing Market Share by Type (2018-2033)
9.3 Asia Lung Cancer Genomic Testing Market Size by Application
9.3.1 Asia Lung Cancer Genomic Testing Market Size by Application (2018-2023)
9.3.2 Asia Lung Cancer Genomic Testing Market Size by Application (2024-2033)
9.3.3 Asia Lung Cancer Genomic Testing Market Share by Application (2018-2033)
9.4 Asia Lung Cancer Genomic Testing Market Size by Region
9.4.1 Asia Lung Cancer Genomic Testing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Lung Cancer Genomic Testing Market Size by Region (2018-2023)
9.4.3 Asia Lung Cancer Genomic Testing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 CD Genomics
11.1.1 CD Genomics Company Details
11.1.2 CD Genomics Business Overview
11.1.3 CD Genomics Lung Cancer Genomic Testing Introduction
11.1.4 CD Genomics Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.1.5 CD Genomics Recent Developments
11.2 Qiagen NV
11.2.1 Qiagen NV Company Details
11.2.2 Qiagen NV Business Overview
11.2.3 Qiagen NV Lung Cancer Genomic Testing Introduction
11.2.4 Qiagen NV Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.2.5 Qiagen NV Recent Developments
11.3 Laboratory Corporation of America Holdings
11.3.1 Laboratory Corporation of America Holdings Company Details
11.3.2 Laboratory Corporation of America Holdings Business Overview
11.3.3 Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Introduction
11.3.4 Laboratory Corporation of America Holdings Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.3.5 Laboratory Corporation of America Holdings Recent Developments
11.4 NeoGenomics Laboratories
11.4.1 NeoGenomics Laboratories Company Details
11.4.2 NeoGenomics Laboratories Business Overview
11.4.3 NeoGenomics Laboratories Lung Cancer Genomic Testing Introduction
11.4.4 NeoGenomics Laboratories Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.4.5 NeoGenomics Laboratories Recent Developments
11.5 Agilent Technologies Inc.
11.5.1 Agilent Technologies Inc. Company Details
11.5.2 Agilent Technologies Inc. Business Overview
11.5.3 Agilent Technologies Inc. Lung Cancer Genomic Testing Introduction
11.5.4 Agilent Technologies Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.5.5 Agilent Technologies Inc. Recent Developments
11.6 Illumina Inc.
11.6.1 Illumina Inc. Company Details
11.6.2 Illumina Inc. Business Overview
11.6.3 Illumina Inc. Lung Cancer Genomic Testing Introduction
11.6.4 Illumina Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.6.5 Illumina Inc. Recent Developments
11.7 Thermo Fischer Scientific Inc.
11.7.1 Thermo Fischer Scientific Inc. Company Details
11.7.2 Thermo Fischer Scientific Inc. Business Overview
11.7.3 Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Introduction
11.7.4 Thermo Fischer Scientific Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.7.5 Thermo Fischer Scientific Inc. Recent Developments
11.8 Abbott Laboratories Inc.
11.8.1 Abbott Laboratories Inc. Company Details
11.8.2 Abbott Laboratories Inc. Business Overview
11.8.3 Abbott Laboratories Inc. Lung Cancer Genomic Testing Introduction
11.8.4 Abbott Laboratories Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.8.5 Abbott Laboratories Inc. Recent Developments
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Details
11.9.2 Quest Diagnostics Inc. Business Overview
11.9.3 Quest Diagnostics Inc. Lung Cancer Genomic Testing Introduction
11.9.4 Quest Diagnostics Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.9.5 Quest Diagnostics Inc. Recent Developments
11.10 OncoDNA
11.10.1 OncoDNA Company Details
11.10.2 OncoDNA Business Overview
11.10.3 OncoDNA Lung Cancer Genomic Testing Introduction
11.10.4 OncoDNA Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.10.5 OncoDNA Recent Developments
11.11 Centogene N.V.
11.11.1 Centogene N.V. Company Details
11.11.2 Centogene N.V. Business Overview
11.11.3 Centogene N.V. Lung Cancer Genomic Testing Introduction
11.11.4 Centogene N.V. Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.11.5 Centogene N.V. Recent Developments
11.12 Admera Health
11.12.1 Admera Health Company Details
11.12.2 Admera Health Business Overview
11.12.3 Admera Health Lung Cancer Genomic Testing Introduction
11.12.4 Admera Health Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.12.5 Admera Health Recent Developments
11.13 CeGaT GmbH
11.13.1 CeGaT GmbH Company Details
11.13.2 CeGaT GmbH Business Overview
11.13.3 CeGaT GmbH Lung Cancer Genomic Testing Introduction
11.13.4 CeGaT GmbH Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.13.5 CeGaT GmbH Recent Developments
11.14 OPKO Health Inc.
11.14.1 OPKO Health Inc. Company Details
11.14.2 OPKO Health Inc. Business Overview
11.14.3 OPKO Health Inc. Lung Cancer Genomic Testing Introduction
11.14.4 OPKO Health Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.14.5 OPKO Health Inc. Recent Developments
11.15 F. Hoffmann-La Roche AG.
11.15.1 F. Hoffmann-La Roche AG. Company Details
11.15.2 F. Hoffmann-La Roche AG. Business Overview
11.15.3 F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Introduction
11.15.4 F. Hoffmann-La Roche AG. Revenue in Lung Cancer Genomic Testing Business (2018-2023)
11.15.5 F. Hoffmann-La Roche AG. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Lung Cancer Genomic Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Liquid Biopsy
Table 3. Key Players of Tissue Biopsy
Table 4. Global Lung Cancer Genomic Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Lung Cancer Genomic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Lung Cancer Genomic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Lung Cancer Genomic Testing Market Share by Region (2018-2023)
Table 8. Global Lung Cancer Genomic Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Lung Cancer Genomic Testing Market Share by Region (2024-2033)
Table 10. Lung Cancer Genomic Testing Market Trends
Table 11. Lung Cancer Genomic Testing Market Drivers
Table 12. Lung Cancer Genomic Testing Market Challenges
Table 13. Lung Cancer Genomic Testing Market Restraints
Table 14. Global Lung Cancer Genomic Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Lung Cancer Genomic Testing Revenue Share by Players (2018-2023)
Table 16. Global Top Lung Cancer Genomic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Genomic Testing as of 2022)
Table 17. Global Lung Cancer Genomic Testing Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Lung Cancer Genomic Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Lung Cancer Genomic Testing, Headquarters and Area Served
Table 20. Global Key Players of Lung Cancer Genomic Testing, Product and Application
Table 21. Global Key Players of Lung Cancer Genomic Testing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lung Cancer Genomic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Lung Cancer Genomic Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Lung Cancer Genomic Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Lung Cancer Genomic Testing Revenue Market Share by Type (2024-2033)
Table 27. Global Lung Cancer Genomic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Lung Cancer Genomic Testing Revenue Share by Application (2018-2023)
Table 29. Global Lung Cancer Genomic Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Lung Cancer Genomic Testing Revenue Share by Application (2024-2033)
Table 31. North America Lung Cancer Genomic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Lung Cancer Genomic Testing Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Lung Cancer Genomic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Lung Cancer Genomic Testing Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Lung Cancer Genomic Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Lung Cancer Genomic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Lung Cancer Genomic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Lung Cancer Genomic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Lung Cancer Genomic Testing Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Lung Cancer Genomic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Lung Cancer Genomic Testing Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Lung Cancer Genomic Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Lung Cancer Genomic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Lung Cancer Genomic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Lung Cancer Genomic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Lung Cancer Genomic Testing Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Lung Cancer Genomic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Lung Cancer Genomic Testing Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Lung Cancer Genomic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Lung Cancer Genomic Testing Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Lung Cancer Genomic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Lung Cancer Genomic Testing Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Lung Cancer Genomic Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Lung Cancer Genomic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Lung Cancer Genomic Testing Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 63. CD Genomics Company Details
Table 64. CD Genomics Business Overview
Table 65. CD Genomics Lung Cancer Genomic Testing Product
Table 66. CD Genomics Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 67. CD Genomics Recent Developments
Table 68. Qiagen NV Company Details
Table 69. Qiagen NV Business Overview
Table 70. Qiagen NV Lung Cancer Genomic Testing Product
Table 71. Qiagen NV Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 72. Qiagen NV Recent Developments
Table 73. Laboratory Corporation of America Holdings Company Details
Table 74. Laboratory Corporation of America Holdings Business Overview
Table 75. Laboratory Corporation of America Holdings Lung Cancer Genomic Testing Product
Table 76. Laboratory Corporation of America Holdings Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 77. Laboratory Corporation of America Holdings Recent Developments
Table 78. NeoGenomics Laboratories Company Details
Table 79. NeoGenomics Laboratories Business Overview
Table 80. NeoGenomics Laboratories Lung Cancer Genomic Testing Product
Table 81. NeoGenomics Laboratories Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 82. NeoGenomics Laboratories Recent Developments
Table 83. Agilent Technologies Inc. Company Details
Table 84. Agilent Technologies Inc. Business Overview
Table 85. Agilent Technologies Inc. Lung Cancer Genomic Testing Product
Table 86. Agilent Technologies Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 87. Agilent Technologies Inc. Recent Developments
Table 88. Illumina Inc. Company Details
Table 89. Illumina Inc. Business Overview
Table 90. Illumina Inc. Lung Cancer Genomic Testing Product
Table 91. Illumina Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 92. Illumina Inc. Recent Developments
Table 93. Thermo Fischer Scientific Inc. Company Details
Table 94. Thermo Fischer Scientific Inc. Business Overview
Table 95. Thermo Fischer Scientific Inc. Lung Cancer Genomic Testing Product
Table 96. Thermo Fischer Scientific Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 97. Thermo Fischer Scientific Inc. Recent Developments
Table 98. Abbott Laboratories Inc. Company Details
Table 99. Abbott Laboratories Inc. Business Overview
Table 100. Abbott Laboratories Inc. Lung Cancer Genomic Testing Product
Table 101. Abbott Laboratories Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 102. Abbott Laboratories Inc. Recent Developments
Table 103. Quest Diagnostics Inc. Company Details
Table 104. Quest Diagnostics Inc. Business Overview
Table 105. Quest Diagnostics Inc. Lung Cancer Genomic Testing Product
Table 106. Quest Diagnostics Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 107. Quest Diagnostics Inc. Recent Developments
Table 108. OncoDNA Company Details
Table 109. OncoDNA Business Overview
Table 110. OncoDNA Lung Cancer Genomic Testing Product
Table 111. OncoDNA Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 112. OncoDNA Recent Developments
Table 113. Centogene N.V. Company Details
Table 114. Centogene N.V. Business Overview
Table 115. Centogene N.V. Lung Cancer Genomic Testing Product
Table 116. Centogene N.V. Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 117. Centogene N.V. Recent Developments
Table 118. Admera Health Company Details
Table 119. Admera Health Business Overview
Table 120. Admera Health Lung Cancer Genomic Testing Product
Table 121. Admera Health Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 122. Admera Health Recent Developments
Table 123. CeGaT GmbH Company Details
Table 124. CeGaT GmbH Business Overview
Table 125. CeGaT GmbH Lung Cancer Genomic Testing Product
Table 126. CeGaT GmbH Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 127. CeGaT GmbH Recent Developments
Table 128. OPKO Health Inc. Company Details
Table 129. OPKO Health Inc. Business Overview
Table 130. OPKO Health Inc. Lung Cancer Genomic Testing Product
Table 131. OPKO Health Inc. Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 132. OPKO Health Inc. Recent Developments
Table 133. F. Hoffmann-La Roche AG. Company Details
Table 134. F. Hoffmann-La Roche AG. Business Overview
Table 135. F. Hoffmann-La Roche AG. Lung Cancer Genomic Testing Product
Table 136. F. Hoffmann-La Roche AG. Revenue in Lung Cancer Genomic Testing Business (2018-2023) & (US$ Million)
Table 137. F. Hoffmann-La Roche AG. Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Genomic Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Lung Cancer Genomic Testing Market Share by Type: 2022 VS 2033
Figure 3. Liquid Biopsy Features
Figure 4. Tissue Biopsy Features
Figure 5. Global Lung Cancer Genomic Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Lung Cancer Genomic Testing Market Share by Application: 2022 VS 2033
Figure 7. Hospitals/Clinics Case Studies
Figure 8. Research Organization Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Lung Cancer Genomic Testing Report Years Considered
Figure 11. Global Lung Cancer Genomic Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Lung Cancer Genomic Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Lung Cancer Genomic Testing Market Share by Region: 2022 VS 2033
Figure 14. Global Lung Cancer Genomic Testing Market Share by Players in 2022
Figure 15. Global Top Lung Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Genomic Testing as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Lung Cancer Genomic Testing Revenue in 2022
Figure 17. North America Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Lung Cancer Genomic Testing Market Share by Type (2018-2033)
Figure 19. North America Lung Cancer Genomic Testing Market Share by Application (2018-2033)
Figure 20. North America Lung Cancer Genomic Testing Market Share by Country (2018-2033)
Figure 21. United States Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Lung Cancer Genomic Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Lung Cancer Genomic Testing Market Share by Type (2018-2033)
Figure 25. Europe Lung Cancer Genomic Testing Market Share by Application (2018-2033)
Figure 26. Europe Lung Cancer Genomic Testing Market Share by Country (2018-2033)
Figure 27. Germany Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Lung Cancer Genomic Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Lung Cancer Genomic Testing Market Share by Type (2018-2033)
Figure 35. China Lung Cancer Genomic Testing Market Share by Application (2018-2033)
Figure 36. Asia Lung Cancer Genomic Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Lung Cancer Genomic Testing Market Share by Type (2018-2033)
Figure 38. Asia Lung Cancer Genomic Testing Market Share by Application (2018-2033)
Figure 39. Asia Lung Cancer Genomic Testing Market Share by Region (2018-2033)
Figure 40. Japan Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Lung Cancer Genomic Testing Market Share by Country (2018-2033)
Figure 50. Brazil Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Lung Cancer Genomic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. CD Genomics Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 57. Qiagen NV Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 58. Laboratory Corporation of America Holdings Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 59. NeoGenomics Laboratories Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 60. Agilent Technologies Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 61. Illumina Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 62. Thermo Fischer Scientific Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 63. Abbott Laboratories Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 64. Quest Diagnostics Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 65. OncoDNA Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 66. Centogene N.V. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 67. Admera Health Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 68. CeGaT GmbH Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 69. OPKO Health Inc. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 70. F. Hoffmann-La Roche AG. Revenue Growth Rate in Lung Cancer Genomic Testing Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed